Jupiter Neurosciences, Inc.
JUNS
$3.20
-$0.08-2.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 64.70K | 40.50K | 21.80K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 64.70K | 40.50K | 21.80K | -- | -- |
| Cost of Revenue | 1.88M | 2.04M | 2.09M | 2.24M | 1.52M |
| Gross Profit | -1.82M | -2.00M | -2.07M | -2.24M | -1.52M |
| SG&A Expenses | 7.99M | 7.33M | 6.84M | 5.31M | 4.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.88M | 9.37M | 8.93M | 7.56M | 5.75M |
| Operating Income | -9.81M | -9.33M | -8.91M | -7.56M | -5.75M |
| Income Before Tax | -9.20M | -9.18M | -8.64M | -7.60M | -5.90M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.20 | -9.18 | -8.64 | -7.60 | -5.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.20M | -9.18M | -8.64M | -7.60M | -5.90M |
| EBIT | -9.81M | -9.33M | -8.91M | -7.56M | -5.75M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -18.57 | -19.58 | -18.66 | -17.22 | -13.60 |
| Normalized Basic EPS | -12.57 | -12.58 | -12.01 | -10.62 | -8.36 |
| EPS Diluted | -18.59 | -19.60 | -18.68 | -17.22 | -13.60 |
| Normalized Diluted EPS | -12.57 | -12.58 | -12.01 | -10.62 | -8.36 |
| Average Basic Shares Outstanding | 1.99M | 1.88M | 1.85M | 1.76M | 1.72M |
| Average Diluted Shares Outstanding | 1.99M | 1.88M | 1.85M | 1.76M | 1.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |